Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT.

Source:http://linkedlifedata.com/resource/pubmed/id/21387274

Cancer 2011 Sep 15 117 18 4141-54

Download in:

View as

General Info

PMID
21387274